These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 28306364

  • 1. White orbital mass after enucleation for retinoblastoma: The power of illusion.
    Soliman SE, Halliday W, Shaikh F, Chan H, Hèon E, Gallie BL.
    Ophthalmic Genet; 2017 Dec; 38(6):584-586. PubMed ID: 28306364
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL, Alset AE, Say EA, Caywood E, Jabbour P, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2016 Sep 01; 53(5):275-84. PubMed ID: 27486728
    [Abstract] [Full Text] [Related]

  • 8. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications.
    Lang P, Kim JW, McGovern K, Reid MW, Subramanian K, Murphree AL, Berry JL.
    Orbit; 2018 Dec 01; 37(6):438-443. PubMed ID: 29461921
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological investigation of a retinoblastoma eye enucleated after vitreous surgery with melphalan perfusion.
    Ohshima KI, Kaneko T, Takagi S, Kaneko A, Yokouchi Y, Takeuchi S.
    Jpn J Ophthalmol; 2009 Mar 01; 53(2):186-188. PubMed ID: 19333708
    [No Abstract] [Full Text] [Related]

  • 10. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW.
    Int Ophthalmol Clin; 2015 Mar 01; 55(1):77-96. PubMed ID: 25436495
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
    Vajzovic LM, Murray TG, Aziz-Sultan MA, Schefler AC, Fernandes CE, Wolfe SC, Hess DJ, Dubovy SR.
    Arch Ophthalmol; 2010 Dec 01; 128(12):1619-23. PubMed ID: 21149791
    [No Abstract] [Full Text] [Related]

  • 18. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA, Sachdev N, Staffieri SE, McKenzie JD, Elder JE.
    J AAPOS; 2015 Feb 01; 19(1):72-4. PubMed ID: 25727592
    [Abstract] [Full Text] [Related]

  • 19. Abnormal orbital growth in children submitted to enucleation for retinoblastoma treatment.
    Chojniak MM, Chojniak R, Testa ML, Min TT, Guimarães MD, Barbosa E Silva AM, Antoneli CB.
    J Pediatr Hematol Oncol; 2012 Apr 01; 34(3):e102-5. PubMed ID: 22258347
    [Abstract] [Full Text] [Related]

  • 20. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL, Shields JA.
    Curr Opin Ophthalmol; 2010 May 01; 21(3):203-12. PubMed ID: 20224400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.